PBEvsHTECETF Comparison
VS
ETF 2
HTEC
Robo Global Healthcare Technology and Innovation ETF
This fund is part of
Multiple Trends
+1.93%
Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. Robo Global Healthcare Technology and Innovation ETF (HTEC) is part of the Multiple Trends segment. Both ETFs have the same top 3 sector exposures: and Health Care. PBE is less expensive with a Total Expense Ratio (TER) of 0.58%, versus 0.8% for HTEC. PBE is down -2.66% year-to-date (YTD) with -$2M in YTD flows. HTEC performs worse with -5.7% YTD performance, and +$2M in YTD flows. Run a side-by-side ETF comparison of PBE and HTEC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
PBE vs HTEC performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | PBE HTEC | +4.27%+3.31% | -3.98%-10.81% | -2.66%-5.70% | +32.11%+28.69% | +28.24%+9.59% | +3.38%-28.23% |
| Flows | PBE HTEC | +$2M+$2M | -$6M+$2M | -$2M+$2M | -$30M-$2M | -$58M-$47M | -$43M-$80M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | PBE HTEC | +19.57%+21.76% | +19.83%+19.92% | +20.15%+20.15% | +22.54%+23.82% |
| Max drawdown | PBE HTEC | -9.36%-15.87% | -11.70%-16.84% | -22.21%-28.61% | -34.74%-56.05% |
| Max drawdown duration | PBE HTEC | 75d87d | 107d91d | 324d546d | 1540d1694d |
Trading data
PBE | HTEC | |
Last sale 4/27/2026 at 1:30 PM | $79.93 | $33.63 |
| Previous close 04/24/2026 | $79.82 | $33.56 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of March 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
PBE | HTEC | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 4/27/2026 at 1:30 PM
Live
Closed
PBE | HTEC | |
|---|---|---|
| Last price | $79.93 | $33.63 |
| 1D performance | +0.14% | +0.20% |
| AuM | $249.88 M | $51.82 M |
| E/R | 0.58% | 0.8% |
Characteristics
PBE | HTEC | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Invesco | ROBO Global ETFs |
| Benchmark | Dynamic Biotech & Genome Intellidex Index | ROBO Global Healthcare Technology and Innovation |
| N° of holdings | 30 | 55 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 23, 2005 | June 25, 2019 |
| ESG | No | Yes |
Advertisement
Exposure
Countries
PBE
USA
92.18%
Other
7.82%
HTEC
USA
71.15%
Other
28.85%
Sectors
PBE
Health Care
97.59%
Other
2.41%
HTEC
Health Care
86.89%
Other
13.11%
Advertisement
Diversification
PBE
Total weight of top 15 holdings out of 15
63.66%
HTEC
Total weight of top 15 holdings out of 15
30.9%
Top 15 holdings
Data as of March 31, 2026
PBE
UTD THERAPEUT
6.05%
ILLUMINA
5.24%
REGENERON PHARMACEUTICALS
5.23%
ALNYLAM PHARMACEUTICALS
5.22%
BIOGEN INC
5.16%
AMGEN-T
4.99%
GILEAD SCIENCES
4.98%
INCYTE
4.89%
BIOCRYST PHARMACEUTICALS
3.66%
PROTAGONIST THERAPEUTICS INC
3.38%
TG THERAPEUTICS
3.11%
ROYALTY PHARMA
3.05%
NEUROCRINE BIOSCIENCES
2.93%
CATALYST PHARMACEUTICALS INC
2.89%
PTC THERAPEUTI/D
2.86%
HTEC
AXOGEN
2.46%
ARROWHEAD PHARMACEUTICALS INC
2.22%
ALNYLAM PHARMACEUTICALS
2.19%
GUARDANT HEALTH INC
2.15%
NATERA
2.14%
THERMO FISHER SCIENTIFIC
2.07%
VERTEX PHARMACEUTICALS
2.07%
MEDPACE HOLDINGS INC
2.01%
INTUITIVE SURGICAL
1.99%
LIVANOVA
1.98%
REGENERON PHARMACEUTICALS
1.98%
ILLUMINA
1.93%
STRYKER
1.91%
IQVIA HOLDINGS INC
1.90%
UTD THERAPEUT
1.89%
Frequently asked questions about PBE and HTEC
How have the PBE and HTEC ETFs performed in 2026?
As of April 24, 2026, PBE is down -2.66% year-to-date (YTD), while HTEC has lost -5.7%. That puts PBE better performer ahead so far this year.
Which ETF is attracting more investor money: PBE or HTEC?
Year-to-date, the PBE ETF saw -$2M in flows, compared to +$2M for HTEC.
Which ETF is more volatile: PBE or HTEC?
Over the past year, PBE had a volatility of 19.83%, while HTEC experienced 19.92%.
Which ETF is bigger: PBE or HTEC?
As of April 24, 2026, PBE holds $249.88 M in assets under management (AUM), while HTEC manages $51.82 M.
What sectors do the PBE and HTEC ETFs invest in?
PBE leans toward sectors like Health Care. Meanwhile, HTEC focuses on Health Care.
What are the top holdings of the PBE ETF and HTEC ETF?
PBE top holdings include UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS. HTEC holds in its top three: AXOGEN, ARROWHEAD PHARMACEUTICALS INC and ALNYLAM PHARMACEUTICALS.
Which ETF is more diversified: PBE or HTEC?
PBE holds 30 securities with 63.66% of its assets in the top 15. HTEC has 56 securities and a top 15 weight of 30.9%.
Advertisement
Latest news about PBE & HTEC
Advertisement
